| Symbol | RGEN |
|---|---|
| Name | REPLIGEN CORP |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 41 SEYON STREET, WALTHAM, MA 02453 |
| Telephone | 7814499560 |
| Fax | — |
| — | |
| Website | https://www.repligen.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000730272 |
| Description | Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The companys customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the companys revenue is generated in North America. Additional info from NASDAQ: |
📋 Garland Jason K (Officer) plans to sell 733 shares of REPLIGEN CORP (at $145.00 each, total $106K) Filed: Jun 25, 2026 | ID: 004882
Read moreRepligen Corporation to Present at William Blair 46th Annual Growth Stock Conference
Read moreRepligen Announces Publication of the Company’s 2025 Corporate Sustainability Report
Read moreKonstantinov Konstantin 🟢 acquired 3.2K shares (1 derivative) of REPLIGEN CORP (RGEN) at $103.38 Transaction Date: May 14, 2026 | Filing ID: 228897
Read moreDAWES KAREN A 🟢 acquired 3.2K shares (1 derivative) of REPLIGEN CORP (RGEN) at $103.38 Transaction Date: May 14, 2026 | Filing ID: 228884
Read moreMUIR GLENN P 🟢 acquired 3.2K shares (1 derivative) of REPLIGEN CORP (RGEN) at $103.38 Transaction Date: May 14, 2026 | Filing ID: 228891
Read moreBARTHELEMY NICOLAS 🟢 acquired 3.2K shares (1 derivative) of REPLIGEN CORP (RGEN) at $103.38 Transaction Date: May 14, 2026 | Filing ID: 228883
Read moreMUIR GLENN P 🟢 acquired 4.9K shares (1 derivative) of REPLIGEN CORP (RGEN) at $38.76 Transaction Date: May 07, 2026 | Filing ID: 214293
Read moreDouglass Brian Robb 🔴 sold 334 shares of REPLIGEN CORP (RGEN) at $126.43 Transaction Date: May 07, 2026 | Filing ID: 214265
Read more